MedTrace Logo

PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery

NCT00003429 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-12-18

No results posted yet for this study

Summary

RATIONALE: New imaging procedures such as fludeoxyglucose F 18 PET scan may improve the ability to detect cancer or recurrence of cancer.

PURPOSE: Clinical trial to study the effectiveness of fludeoxyglucose F 18 PET scan in diagnosing primary or recurrent cervical cancer in patients who are undergoing surgery.

Conditions

Interventions

PROCEDURE

biopsy

PROCEDURE

computed tomography

PROCEDURE

positron emission tomography

RADIATION

fludeoxyglucose F 18

Sponsors & Collaborators

Principal Investigators

  • Steven M. Larson, MD · Memorial Sloan Kettering Cancer Center

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Primary Completion
2002-10-31
Completion
2002-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003429 on ClinicalTrials.gov